From: Antibiotic prophylaxis in ragged placental membranes: a prospective, multicentre, randomized trial
Characteristics | Prophylaxis n = 332 | No prophylaxis n = 338 | P-value |
---|---|---|---|
Baseline | |||
Age (years) | 28.04 (5.67) | 28.00 (6.02) | 0.94 |
Parity (number) | 2.42 (1.30) | 2.40 (1.48) | 0.83 |
BMI (kg/m2) | 25.15 (5.22) | 24.51 (5.18) | 0.11 |
Smoking | 7 (2.1%) | 4 (1.2%) | 0.38 |
Previous preterm < 34 weeks | 10 (3.0%) | 8 (2.4%) | 0.60 |
Sexually transmitted disease | 0 (0.0%) | 0 (0.0%) | – |
Intrapartum | |||
Gestation at delivery (weeks) | 38.63 (1.68) | 38.61 (1.67) | 0.84 |
Internal fetal monitoring | 0 (0.0%) | 5 (1.48%) | 0.06** |
Instrumental delivery | 16 (4.80%) | 19 (5.20%) | 0.64 |
Second stage duration (min)* | 7 | 8 | 0.07 |
Number of vaginal examinations | 4 (2) | 4 (2) | 0.34 |